Why the DAWN2™ study?
Despite the progress made since the original DAWN™ study in 2001, the impact of the psychosocial burden of diabetes is still not fully recognised. Many people with diabetes still face significant challenges in areas including self-management, adherence, access to support and involvement in care. Healthcare systems are struggling to accommodate person-centred models of care and to encourage people with diabetes to self-manage their condition. All this is happening while the internet and social media – is opening up unprecedented opportunities for social support and empowerment.
Therefore, collaborative action across countries to improve self-management and psychosocial support is required. Also required is a deeper understanding of the psychosocial issues and unmet needs experienced by people with diabetes, as well as the barriers and facilitators to person-centred chronic care from the point of view of the different stakeholders.
As a response to these challenges and opportunities, a network of international experts and organisations, in partnership with and supported by Novo Nordisk, initiated the DAWN2™ study in 2011. The study builds on the experience gained by researchers in the behavioural and psychological sciences since the first DAWN™ study in 2001.
DAWN2™: a global study initiative
DAWN2™ is a global study conducted in collaboration with the International Diabetes Federation (IDF), the International Alliance of Patient Organizations (IAPO), the Steno Diabetes Center and a range of other national, regional and global partners.
The three main objectives of the DAWN2™ study initiative are to:
- advance understanding and awareness of the unmet needs of people with diabetes and their families
- facilitate dialogue and collaboration to strengthen patient involvement and improve self-management and psychosocial support in diabetes care
- establish a multi-national scientific benchmarking system for person-centred diabetes care and health policy
DAWN2™ is a long-term commitment and an on-going initiative with the aim of inspiring new, sustainable ways to enable the millions of people with diabetes around the world to live full, healthy lives and be actively involved in managing their own health and quality of life.
DAWN2™ study: the largest ever global study to explore the unmet needs of people with diabetes
DAWN2™ represents the voice of more than 15,000 people living with or caring for persons with diabetes in 17 countries across 4 continents.
The DAWN2™ results will be used internationally and nationally to facilitate dialogue among patient organisations, healthcare professionals and other key stakeholders to develop ambitious action plans to improve the lives of people with diabetes.